Berkeley, Inc Bristol Myers Squibb CO Transaction History

Berkeley, Inc

$193 Billion
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 04, 2025	SELL	$48.48 - $57.85 $1.79 Million - $2.13 Million	-36,897 Closed	0 $0
Q3 2023 Mar 28, 2025	SELL	$57.89 - $64.73 $469,487 - $524,960	-8,110 Reduced 18.02%	36,897 $2.14 Billion
Q3 2023 Mar 04, 2025	SELL	$57.89 - $64.73 $469,487 - $524,960	-8,110 Reduced 18.02%	36,897 $2.14 Billion
Q2 2023 Mar 28, 2025	BUY	$63.71 - $70.74 $260,191 - $288,902	4,084 Added 9.98%	45,007 $2.88 Billion
Q2 2023 Mar 04, 2025	BUY	$63.71 - $70.74 $260,191 - $288,902	4,084 Added 9.98%	45,007 $2.88 Billion
Q1 2023 Mar 28, 2025	BUY	$65.71 - $74.53 $119,066 - $135,048	1,812 Added 4.63%	40,923 $2.84 Billion
Q1 2023 Mar 04, 2025	BUY	$65.71 - $74.53 $119,066 - $135,048	1,812 Added 4.63%	40,923 $2.84 Billion
Q4 2022 Mar 28, 2025	BUY	$68.48 - $81.09 $2.68 Million - $3.17 Million	39,111 New	39,111 $2.81 Billion
Q4 2022 Mar 04, 2025	SELL	$68.48 - $81.09 $1,985 - $2,351	-29 Reduced 0.07%	39,111 $2.81 Billion
Q3 2022 Mar 28, 2025	BUY	$0.13 - $76.84 $170 - $100,506	1,308 Added 3.46%	39,140 $2.78 Billion
Q3 2022 Mar 04, 2025	BUY	$0.13 - $76.84 $170 - $100,506	1,308 Added 3.46%	39,140 $2.78 Billion
Q2 2022 Mar 28, 2025	BUY	$72.62 - $79.98 $78,647 - $86,618	1,083 Added 2.95%	37,832 $2.91 Billion
Q2 2022 Mar 04, 2025	BUY	$72.62 - $79.98 $78,647 - $86,618	1,083 Added 2.95%	37,832 $2.91 Billion
Q1 2022 Mar 28, 2025	BUY	$61.48 - $73.72 $603,426 - $723,561	9,815 Added 36.44%	36,749 $2.68 Billion
Q1 2022 Mar 04, 2025	BUY	$61.48 - $73.72 $603,426 - $723,561	9,815 Added 36.44%	36,749 $2.68 Billion
Q4 2021 Mar 28, 2025	BUY	$53.63 - $62.52 $551,209 - $642,580	10,278 Added 61.71%	26,934 $1.68 Billion
Q4 2021 Mar 04, 2025	BUY	$53.63 - $62.52 $551,209 - $642,580	10,278 Added 61.71%	26,934 $1.68 Billion
Q3 2021 Mar 28, 2025	BUY	$59.17 - $69.31 $65,915 - $77,211	1,114 Added 7.17%	16,656 $986 Million
Q3 2021 Mar 04, 2025	BUY	$59.17 - $69.31 $65,915 - $77,211	1,114 Added 7.17%	16,656 $986 Million
Q2 2021 Mar 28, 2025	BUY	$61.91 - $67.42 $248,816 - $270,960	4,019 Added 34.88%	15,542 $1.04 Billion
Q2 2021 Mar 04, 2025	BUY	$61.91 - $67.42 $248,816 - $270,960	4,019 Added 34.88%	15,542 $1.04 Billion
Q1 2021 Mar 28, 2025	BUY	$59.34 - $66.74 $683,774 - $769,045	11,523 New	11,523 $727 Million
Q1 2021 Mar 04, 2025	BUY	$59.34 - $66.74 $683,774 - $769,045	11,523 New	11,523 $727 Million

Others Institutions Holding BMY

# of Institutions

2,765

Shares Held

1.56B

Call Options Held

28M

Put Options Held

28.7M

Vanguard Group Inc Valley Forge, PA

190M
Shares

$11.6 Billion
0.19% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.68 Billion
0.15% of portfolio
Jpmorgan Chase & CO New York, NY

96M
Shares

$5.86 Billion
0.44% of portfolio
State Street Corp Boston, MA

95.1M
Shares

$5.8 Billion
0.22% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

60.3M
Shares

$3.68 Billion
0.65% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $130B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley, Inc with notifications on news.

Account